A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Spending on medical devices has held steady for the past two decades as a proportion of U.S. healthcare expenditures, and the price of devices has risen slower than consumer inflation, according to a new industry-funded study. DOTmed News